BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10718213)

  • 1. Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung.
    Papotti M; Croce S; Macrì L; Funaro A; Pecchioni C; Schindler M; Bussolati G
    Diagn Mol Pathol; 2000 Mar; 9(1):47-57. PubMed ID: 10718213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodies.
    Janson ET; Stridsberg M; Gobl A; Westlin JE; Oberg K
    Cancer Res; 1998 Jun; 58(11):2375-8. PubMed ID: 9622077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical demonstration of chromogranins A and B in neuroendocrine tumors of the lung.
    Tötsch M; Müller LC; Hittmair A; Ofner D; Gibbs AR; Schmid KW
    Hum Pathol; 1992 Mar; 23(3):312-6. PubMed ID: 1313391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Correlation with preoperative octreotide scintigraphy.
    Papotti M; Croce S; Bellò M; Bongiovanni M; Allìa E; Schindler M; Bussolati G
    Virchows Arch; 2001 Dec; 439(6):787-97. PubMed ID: 11787852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas.
    Sunday ME; Choi N; Spindel ER; Chin WW; Mark EJ
    Hum Pathol; 1991 Oct; 22(10):1030-9. PubMed ID: 1668786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors.
    Kimura N; Pilichowska M; Date F; Kimura I; Schindler M
    Clin Cancer Res; 1999 Nov; 5(11):3483-7. PubMed ID: 10589762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromogranin A gene expression in non-small cell lung carcinomas.
    Abbona G; Papotti M; Viberti L; Macrĭ L; Stella A; Bussolati G
    J Pathol; 1998 Oct; 186(2):151-6. PubMed ID: 9924430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis.
    Papotti M; Bongiovanni M; Volante M; Allìa E; Landolfi S; Helboe L; Schindler M; Cole SL; Bussolati G
    Virchows Arch; 2002 May; 440(5):461-75. PubMed ID: 12021920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular alterations to human chromosome 3p loci in neuroendocrine lung tumors.
    Kovatich A; Friedland DM; Druck T; Hadaczek P; Huebner K; Comis RL; Hauck W; McCue PA
    Cancer; 1998 Sep; 83(6):1109-17. PubMed ID: 9740075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of somatostatin receptor subtypes sst1 and sst2A in human somatostatin receptor positive tumors.
    Hofland LJ; Liu Q; Van Koetsveld PM; Zuijderwijk J; Van Der Ham F; De Krijger RR; Schonbrunn A; Lamberts SW
    J Clin Endocrinol Metab; 1999 Feb; 84(2):775-80. PubMed ID: 10022452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan technology.
    Pinzani P; Orlando C; Raggi CC; Distante V; Valanzano R; Tricarico C; Maggi M; Serio M; Pazzagli M
    Regul Pept; 2001 Jun; 99(2-3):79-86. PubMed ID: 11384768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ghrelin-producing endocrine tumors of the stomach and intestine.
    Papotti M; Cassoni P; Volante M; Deghenghi R; Muccioli G; Ghigo E
    J Clin Endocrinol Metab; 2001 Oct; 86(10):5052-9. PubMed ID: 11600584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential distribution of the neuron-associated class III beta-tubulin in neuroendocrine lung tumors.
    Katsetos CD; Kontogeorgos G; Geddes JF; Herman MM; Tsimara-Papastamatiou H; Yu Y; Sakkas LI; Tsokos M; Patchefsky AS; Ehya H; Cooper HS; Provencio J; Spano AJ; Frankfurter A
    Arch Pathol Lab Med; 2000 Apr; 124(4):535-44. PubMed ID: 10747310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
    Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
    Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study.
    Hechtman JF; Beasley MB; Kinoshita Y; Ko HM; Hao K; Burstein DE
    Hum Pathol; 2013 Jul; 44(7):1400-5. PubMed ID: 23416030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of somatostatin receptor type 2 gene expression in neuroblastoma cell lines and primary tumors using competitive reverse transcription-polymerase chain reaction.
    Sestini R; Orlando C; Peri A; Tricarico C; Pazzagli M; Serio M; Pagani A; Bussolati G; Granchi S; Maggi M
    Clin Cancer Res; 1996 Oct; 2(10):1757-65. PubMed ID: 9816127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids.
    Sturm N; Rossi G; Lantuejoul S; Papotti M; Frachon S; Claraz C; Brichon PY; Brambilla C; Brambilla E
    Hum Pathol; 2002 Feb; 33(2):175-82. PubMed ID: 11957142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors.
    Lantuejoul S; Moro D; Michalides RJ; Brambilla C; Brambilla E
    Am J Surg Pathol; 1998 Oct; 22(10):1267-76. PubMed ID: 9777989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide Receptor Radionuclide Therapy for Patients With Advanced Lung Carcinoids.
    Naraev BG; Ramirez RA; Kendi AT; Halfdanarson TR
    Clin Lung Cancer; 2019 May; 20(3):e376-e392. PubMed ID: 30910575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.